Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 14 February 2003:
Vol. 299. no. 5609, p. 991
DOI: 10.1126/science.299.5609.991b
Prev | Table of Contents | Next

News of the Week

GENE THERAPY:
RAC Hears a Plea for Resuming Trials, Despite Cancer Risk

Jocelyn Kaiser

After learning more about the leukemias in two patients in a French gene-therapy trial, a U.S. review panel this week suggested that although it makes sense to keep this trial on hold, others might be allowed to resume. The panel also learned that a third patient in the French trial has a gene insertion like the one in the two who developed leukemia--although this child does not have leukemia.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)